FEATURES OF PNEUMONIA COURSE IN ONCOLOGICAL BLOOD DISEASES

Authors

  • A. O. Bob ДВНЗ «Тернопільський державний медичний університет імені І. Я. Горбачевського МОЗ України»
  • A. I. Khomitska ДВНЗ «Тернопільський державний медичний університет імені І. Я. Горбачевського МОЗ України»
  • O. O. Chukur ДВНЗ «Тернопільський державний медичний університет імені І. Я. Горбачевського МОЗ України»
  • L. V. Radetska ДВНЗ «Тернопільський державний медичний університет імені І. Я. Горбачевського МОЗ України»
  • L. P. Bodnar ДВНЗ «Тернопільський державний медичний університет імені І. Я. Горбачевського МОЗ України»
  • O. S. Kvasnitska ДВНЗ «Тернопільський державний медичний університет імені І. Я. Горбачевського МОЗ України»
  • V. Y. Horodetskyi ДВНЗ «Тернопільський державний медичний університет імені І. Я. Горбачевського МОЗ України»

DOI:

https://doi.org/10.11603/1811-2471.2018.v0.i1.8610

Keywords:

pneumonia, oncological diseases of the blood, infectious pathogens.

Abstract

The most common infectious complications of leukemia are pneumonia, which is often the main cause of the death of these patients.

The aim of the work was to determine the etiological factor of pneumonia in patients with severe immune disorders on the background of oncological diseases of the blood.

Material and Methods. 124 patients with pneumonia and oncological diseases of the blood were examined. A microbiological study of sputum and fluid of bronchoalveolar lavage was determined by studying native smears with the definition of the main morphological types of pathogens.

Results. According to the results of microbiological studies, probable bacterial pathogens of the disease were identified in 69.4 % of cases. Among the 89 positive results of microbiological research, gram-negative microorganisms were the leading, accounting for 68.6 %. Gram-positive microorganisms were identified in 26.7 % of the studies. Associations of pathogenic microgranisms have been identified in 53.3 % of patients in the study group: with fungal flora – 52.4 %; the association of bacteria – 26.7 %.

References

Avdeev SN. Application of the method of induced sputum for evaluation of intensity of respiratory tract inflammation / Anaev EKh, Chuchalin A.G.// Pulmo-nologiya.-2010.-№4.-Р. 81-87.

Dzyublik YaO. Clinical aspects of resistence of antimicrobial agents of community acquired respiratory tract infections. //Ukrai'ns'kiy pul'monologichniy zhurnal. -2010.-№3.-Р.53-56.

Non-hospital pneumonia in adults: etiology, pathogenesis, classification, diagnosis, antibiotic bacterial therapy (Project of clinical guidelines) / Yu.I. Feshchenko, OA Golubovskaya, K.A. Goncharov, O.Ya. Dzublyk // Ukrai'ns'kiy pul'monologichniy zhurnal.-2012.-№4.-p.5-17.

Pertseva T.O. Pneumonia in patients with background of oncological diseases of blood / T.O.Pertseva, I.S. Borisova // Clinical Medicine.-2014. №14 Volume XIX / 1.-P.45-49.

Shorr A.F. Quality pneumonia care: distinguishing community-acquired from health careassociated pneumonia/ A.F. Shorr, R.C. Owens // Am. J. Health Syst. Pharm.-2009.-Vol.66,N12,Suppl.4.-P.8-14.

Published

2018-05-22

How to Cite

Bob, A. O., Khomitska, A. I., Chukur, O. O., Radetska, L. V., Bodnar, L. P., Kvasnitska, O. S., & Horodetskyi, V. Y. (2018). FEATURES OF PNEUMONIA COURSE IN ONCOLOGICAL BLOOD DISEASES. Achievements of Clinical and Experimental Medicine, (1). https://doi.org/10.11603/1811-2471.2018.v0.i1.8610

Issue

Section

Погляд на проблему